Frias JP, Hsia S, Eyde S, Liu R, et al. Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study. Lancet 2023 Jun 23:S0140-6736(23)01302-8. doi: 10.1016/S0140-6736(23)01302.
PMID: 37369232